NCT02524041View on ClinicalTrials.gov

Association Between Serum Periostin Levels and Cortical Porosity in Patients With Secondary Hyperparathyroidism

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Hyperparathyroidism
Interventions
DEVICE

HR-pQCT

The Xtrem CT scanco device is a HR-pQCT used for 3D bone measurements at the tibia and the radius levels in humans

OTHER

blood specimen

blood specimen

Trial Locations (1)

42000

CHU de SAINT-ETIENNE, Saint-Etienne

All Listed Sponsors
collaborator

University Hospital, Geneva

OTHER

lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT02524041 - Association Between Serum Periostin Levels and Cortical Porosity in Patients With Secondary Hyperparathyroidism | Biotech Hunter | Biotech Hunter